Repligen
RGEN
#2771
Rank
S$7.84 B
Marketcap
S$139.06
Share price
4.15%
Change (1 day)
-14.91%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): S$0.10 Billion

According to Repligen 's latest financial reports the company's current earnings are S$0.73 Billion. , an increase over its 2024 earnings that were of -S$8.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 S$0.10 B-1430.84%
2024 -S$8.08 Million-113.01%
2023 S$62.08 M-78.01%
2022 S$0.28 B33.37%
2021 S$0.21 B131.52%
2020 S$91.42 M101.31%
2019 S$45.41 M25.93%
2018 S$36.06 M105.61%
2017 S$17.54 M-11.46%
2016 S$19.81 M14.91%
2015 S$17.24 M20.26%
2014 S$14.33 M-51.49%
2013 S$29.55 M90.98%
2012 S$15.47 M
2010 S$0.22 M-103.81%
2009 -S$5.88 Million-223.84%
2008 S$4.74 M
2006 -S$3.19 Million229.64%
2005 -S$0.97 Million-89.16%
2004 -S$8.93 Million-16.86%
2003 -S$10.74 Million88.72%
2002 -S$5.69 Million-27.88%
2001 -S$7.89 Million-1.74%
2000 -S$8.03 Million85.93%
1999 -S$4.32 Million159.16%
1998 -S$1.67 Million85.71%
1997 -S$0.9 Million-70.83%
1996 -S$3.08 Million-72.41%
1995 -S$11.15 Million-60.63%
1994 -S$28.32 Million45.39%
1993 -S$19.48 Million39.45%
1992 -S$13.97 Million-32.3%
1991 -S$20.64 Million6.62%
1990 -S$19.35 Million1577.78%
1989 -S$1.16 Million-57.14%
1988 -S$2.7 Million-362.5%
1987 S$1.02 M-130.77%
1986 -S$3.34 Million136.36%
1985 -S$1.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.57 B 12,523.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$9.51 B 8,746.67%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$14.07 B 12,988.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.29 B 11,339.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-S$0.14 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$0.59 B 453.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$1.02 B 852.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.15 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.49 B 359.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-S$0.13 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA